BioSpace News Archive

Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced that the company will be presenting at the 3rd Annual Chardan Genetic Medicines Conference being held October 7th-October 8th at the Westin Grand Central hotel in New York.

Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, and the CIBMTR® (Center for International Blood and Marrow Transplant Research®) today announced the entry into a research agreement to collect and analyze health outcomes data in patients with hematologic malignancies who receive an allogeneic hematopoietic stem cell transplant (HSCT, or bone marrow transplant) from various donor sources

In only three minutes, rising-star researchers from high schoolers to post-doctoral investigators will highlight their research to more than 150 bioscience professionals, industry experts, enthusiasts, and judges at Oregon Bio 2019: Innovating and Scaling for our Region’s Growth.

The FDA confirmed that the review will have an action date of late April, 2020.

Tennessee Gov. Bill Lee, Department of Economic and Community Development Commissioner Bob Rolfe and HCTec officials announced today that the company will continue to expand its operations in Hohenwald.

Brain Health and Research Institute (BHRI) founder and CEO Dr. Mary Kay Ross announced today a new neurological partnership with Posit Science, the maker of the revolutionary brain training system, BrainHQ.

Seven years after the industry-leading Hazelden Betty Ford Foundation overhauled its approach to treating opioid addiction, research shows its new model is producing successful outcomes.

Kenshō, the first personalized research-backed holistic health discovery platform, today announced that it has closed pre-seed funding co-led by Female Founders Fund and Crosscut Ventures, placing it in the company of Rent The Runway, Billie, and Zola.

Cook Regentec today announced enrollment of the first patient in an international clinical trial evaluating the HemaTrate® Blood Filtration System to treat patients with critical limb ischemia (CLI) due to peripheral arterial disease (PAD).

GP Solutions (OTC:GWPD), developer of automated micro-farms called “GrowPods,” announced it will debut its new system technology and pathogen-free soil at CannaCon in Oklahoma City.